FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2032040317> ?p ?o ?g. }

• W2032040317 endingPage "1267" @default.
• W2032040317 startingPage "1263" @default.
• W2032040317 abstract "Type II endoleak (T2EL) with aneurysm expansion is believed to place patients at risk for aneurysm-related mortality (ARM). Treatment with glue and/or coil embolization of the aneurysm sac, inferior mesenteric artery (IMA), and lumbar branches via translumbar or transarterial approaches has been utilized to ablate such endoleaks, and thus decrease ARM. We evaluated the midterm results of percutaneous endovascular treatment of T2EL with aneurysm expansion.Single-institution, 5-year (January 2003 to August 2008) retrospective study of all endovascular interventions for T2EL with sac expansion. Blinded, independent review of all available pre- and post-T2EL intervention computed tomography (CT) scans was performed. Aneurysm sac maximal transverse diameters and aneurysm sac growth rates prior to and following T2EL intervention were analyzed.Forty-two patients (34 male, eight female; mean age, 75) underwent T2EL intervention at 26 ± 20 months after endovascular aneurysm repair (EVAR) and were subsequently followed for 23 ± 20 months. Seven out of 42 patients (17%) underwent repeat T2EL intervention. Interventions included 44 translumbar sac embolizations, and transcatheter embolizations of nine IMAs and seven lumbar/hypogastric arteries. Aneurysm diameter was 6.1 ± 1.6 cm at EVAR, 6.6 ± 1.5 cm at initial T2EL treatment, and 6.9 ± 1.7 cm at last follow-up. There were no significant differences in the rates of aneurysm sac growth pre- and post-T2EL treatment. At last follow-up imaging, recurrent or persistent T2EL was noted in 72% of patients. Of 42 patients, nine (21%) received operative endoluminal correction of occult type I or type III endoleaks that were diagnosed during the T2EL angiographic intervention. There were no aneurysm ruptures or ARMs during follow-up; overall mortality for the 5-year study period was 24%.In this series, percutaneous endovascular intervention for type II endoleak with aneurysm sac growth does not appear to alter the rate of aneurysm sac growth, and the majority of patients display persistent/recurrent endoleak. However, diagnostic angiographic evaluation may reveal unexpected type I and III endoleaks and is therefore recommended for all patients with T2EL and sac growth. While coil and glue embolization of aneurysm sac and selected branch vessels does not appear to yield benefit in our series, the diagnosis and subsequent definitive treatment of previously occult type I and III endoleaks may explain the absence of delayed rupture and ARM in our series." @default.
• W2032040317 created "2016-06-24" @default.
• W2032040317 creator A5001143892 @default.
• W2032040317 creator A5021369727 @default.
• W2032040317 creator A5037720100 @default.
• W2032040317 creator A5042216787 @default.
• W2032040317 creator A5049010539 @default.
• W2032040317 creator A5050638660 @default.
• W2032040317 creator A5075931249 @default.
• W2032040317 creator A5081199573 @default.
• W2032040317 date "2012-05-01" @default.
• W2032040317 modified "2023-10-16" @default.
• W2032040317 title "Outcomes of percutaneous endovascular intervention for type II endoleak with aneurysm expansion" @default.
• W2032040317 cites W1838534864 @default.
• W2032040317 cites W1964954898 @default.
• W2032040317 cites W1969714012 @default.
• W2032040317 cites W1970476005 @default.
• W2032040317 cites W1975638424 @default.
• W2032040317 cites W1982143401 @default.
• W2032040317 cites W1996661019 @default.
• W2032040317 cites W2000903517 @default.
• W2032040317 cites W2024641271 @default.
• W2032040317 cites W2025351458 @default.
• W2032040317 cites W2042509996 @default.
• W2032040317 cites W2043312845 @default.
• W2032040317 cites W2058150413 @default.
• W2032040317 cites W2064015577 @default.
• W2032040317 cites W2082900613 @default.
• W2032040317 cites W2098181773 @default.
• W2032040317 cites W2122348272 @default.
• W2032040317 cites W2135815452 @default.
• W2032040317 cites W2144357821 @default.
• W2032040317 cites W2156680404 @default.
• W2032040317 doi "https://doi.org/10.1016/j.jvs.2011.10.131" @default.
• W2032040317 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/22322122" @default.
• W2032040317 hasPublicationYear "2012" @default.
• W2032040317 type Work @default.
• W2032040317 sameAs 2032040317 @default.
• W2032040317 citedByCount "106" @default.
• W2032040317 countsByYear W20320403172012 @default.
• W2032040317 countsByYear W20320403172013 @default.
• W2032040317 countsByYear W20320403172014 @default.
• W2032040317 countsByYear W20320403172015 @default.
• W2032040317 countsByYear W20320403172016 @default.
• W2032040317 countsByYear W20320403172017 @default.
• W2032040317 countsByYear W20320403172018 @default.
• W2032040317 countsByYear W20320403172019 @default.
• W2032040317 countsByYear W20320403172020 @default.
• W2032040317 countsByYear W20320403172021 @default.
• W2032040317 countsByYear W20320403172022 @default.
• W2032040317 countsByYear W20320403172023 @default.
• W2032040317 crossrefType "journal-article" @default.
• W2032040317 hasAuthorship W2032040317A5001143892 @default.
• W2032040317 hasAuthorship W2032040317A5021369727 @default.
• W2032040317 hasAuthorship W2032040317A5037720100 @default.
• W2032040317 hasAuthorship W2032040317A5042216787 @default.
• W2032040317 hasAuthorship W2032040317A5049010539 @default.
• W2032040317 hasAuthorship W2032040317A5050638660 @default.
• W2032040317 hasAuthorship W2032040317A5075931249 @default.
• W2032040317 hasAuthorship W2032040317A5081199573 @default.
• W2032040317 hasBestOaLocation W20320403171 @default.
• W2032040317 hasConcept C126838900 @default.
• W2032040317 hasConcept C141071460 @default.
• W2032040317 hasConcept C2776035437 @default.
• W2032040317 hasConcept C2776098176 @default.
• W2032040317 hasConcept C2776543907 @default.
• W2032040317 hasConcept C2778784962 @default.
• W2032040317 hasConcept C2779993416 @default.
• W2032040317 hasConcept C2780601773 @default.
• W2032040317 hasConcept C2780813298 @default.
• W2032040317 hasConcept C71924100 @default.
• W2032040317 hasConceptScore W2032040317C126838900 @default.
• W2032040317 hasConceptScore W2032040317C141071460 @default.
• W2032040317 hasConceptScore W2032040317C2776035437 @default.
• W2032040317 hasConceptScore W2032040317C2776098176 @default.
• W2032040317 hasConceptScore W2032040317C2776543907 @default.
• W2032040317 hasConceptScore W2032040317C2778784962 @default.
• W2032040317 hasConceptScore W2032040317C2779993416 @default.
• W2032040317 hasConceptScore W2032040317C2780601773 @default.
• W2032040317 hasConceptScore W2032040317C2780813298 @default.
• W2032040317 hasConceptScore W2032040317C71924100 @default.
• W2032040317 hasIssue "5" @default.
• W2032040317 hasLocation W20320403171 @default.
• W2032040317 hasLocation W20320403172 @default.
• W2032040317 hasOpenAccess W2032040317 @default.
• W2032040317 hasPrimaryLocation W20320403171 @default.
• W2032040317 hasRelatedWork W2003502161 @default.
• W2032040317 hasRelatedWork W2033741498 @default.
• W2032040317 hasRelatedWork W2139703985 @default.
• W2032040317 hasRelatedWork W2514064330 @default.
• W2032040317 hasRelatedWork W2606959096 @default.
• W2032040317 hasRelatedWork W2769551869 @default.
• W2032040317 hasRelatedWork W2903442303 @default.
• W2032040317 hasRelatedWork W3035063788 @default.
• W2032040317 hasRelatedWork W4210762746 @default.
• W2032040317 hasRelatedWork W4284966660 @default.
• W2032040317 hasVolume "55" @default.
• W2032040317 isParatext "false" @default.

• next